NBC News: New Alzheimer's drug comes with steep price tag
January 11, 2023
The University of Cincinnati's Alberto Espay, MD, spoke with NBC News about the impact of the cost of newly approved Alzheimer's drug Leqembi.
January 11, 2023
The University of Cincinnati's Alberto Espay, MD, spoke with NBC News about the impact of the cost of newly approved Alzheimer's drug Leqembi.
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.
January 27, 2023
The Institute for Healthcare Improvement featured insights from the University of Cincinnati's Jennifer Molano, MD, in articles about promoting joy and well-being in health care workplace settings.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.
February 14, 2023
The University of Cincinnati's Joseph Broderick provided comments to Medscape about new trial data that found performing endovascular thrombectomy in stroke patients with a large ischemic core is beneficial.
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
August 12, 2022
The University of Cincinnati's Alberto Espay, MD, joined WVXU's Cincinnati Edition to discuss recent allegations that a key 2006 Alzheimer's study from the University of Minnesota may have been fabricated.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.